Jointown Pharmaceutical Group Co.,Ltd. Fundamental Rankings

This page is comprehensive fundamental data for Jointown Pharmaceutical Group Co.,Ltd.. Fundamentals are ordered by how Jointown Pharmaceutical Group Co.,Ltd. ranks compared to other companies (ordered high to low). All money values are in CNY. All data is powered by Quandl.

Cite in Wikipedia:

Indicator Value n/price Rank Date Historic
Other receivables2,484,233,9340.09445382015-06-30historic
Cash outflows from operating activities27,706,842,3681.05338452015-06-30historic
Total cost of goods sold23,563,923,4290.89587522015-06-30historic
Revenue23,893,556,1090.90841522015-06-30historic
Cash from issuing bonds1,900,000,0000.07224552015-06-30historic
Cash inflows from operating activities24,885,981,1120.94614732015-06-30historic
Cash from minority shareholders of subsidiaries47,945,2360.00182772015-06-30historic
Net cashflow from financing activities3,419,465,3550.13832015-06-30historic
Accounts payable5,531,164,2130.210291182015-06-30historic
Notes receivable1,316,006,5050.050031222015-06-30historic
Prepayment1,439,093,7260.054711252015-06-30historic
Non-operating loss14,750,8065.6E-41522015-06-30historic
Selling expenses588,213,5370.022361552015-06-30historic
Interests payable82,975,7860.003151642015-06-30historic
Inventories6,165,470,0280.23441732015-06-30historic
Short term borrowings5,515,729,8280.20971832015-06-30historic
Cash inflows from financing activities7,547,176,1970.286931882015-06-30historic
Financial expenses248,836,2950.009462082015-06-30historic
Total liabilities19,698,040,6400.74892422015-06-30historic
Long term equity investment615,448,3530.02342582015-06-30historic
Total liabilities and equity28,205,573,0421.072342862015-06-30historic
Purchases of fixed assets and others458,058,1290.017413172015-06-30historic
Disposal of fixed assets and others2,235,0688.0E-53342015-06-30historic
Cash paid for taxes410,455,7970.015613412015-06-30historic
Cash paid for other investing activities646,0002.0E-53592015-06-30historic
Intangible assets750,276,1670.028523832015-06-30historic
Capital reserve3,954,662,9610.150353922015-06-30historic
Goodwill80,785,3390.003074002015-06-30historic
Minority interest353,212,8760.013434252015-06-30historic
Other payables410,236,2560.01564552015-06-30historic
Proceeds from sell of investment37,670,4330.001434632015-06-30historic
Operating profit343,672,9270.013074652015-06-30historic
Net cash and cash equivalents ending balance1,925,644,8370.073214872015-06-30historic
Total profit355,555,3770.013524952015-06-30historic
Cash from other investing activities28,0000.05082015-06-30historic
Comprehensive income attributable to minority shareholders2,032,7988.0E-55122015-06-30historic
Minority interests gain2,032,7988.0E-55222015-06-30historic
Total comprehensive income280,711,5350.010675442015-06-30historic
Investment income from associate and joint venture-8,863,079-3.4E-45562015-06-30historic
Cash paid for other financing activities6,833,0002.6E-45652015-06-30historic
Cash paid for dividends, profits or interests197,036,0530.007495662015-06-30historic
Net income252,590,7430.00965742015-06-30historic
Fixed assets2,613,884,4840.099385762015-06-30historic
Total non-current assets4,935,550,5150.187646492015-06-30historic
Refunds of taxes2,676,9691.0E-46962015-06-30historic
Deferred tax assets38,230,3210.001457972015-06-30historic
Diluted eps00.09662015-06-30historic
Payroll payable22,866,7168.7E-49902015-06-30historic
Net change in cash-372,640,743-0.014179952015-06-30historic
Net cash flows from investing activities-971,244,842-0.0369310852015-06-30historic